A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs)

Clinical trial NCT07743190 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07743190
Sponsor: Medical University of South Carolina
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Triple Negative Breast Cancer (TNBC)Elevated Tumor-Infiltrating Lymphocytes

Start date: 2026-10-01
Primary completion: 2029-03-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.